A randomised trial of 45 minutes and 15 minutes incremental oxytocin infusion regimes for the induction of labour in women of high parity
- PMID: 8476802
- DOI: 10.1111/j.1471-0528.1993.tb15206.x
A randomised trial of 45 minutes and 15 minutes incremental oxytocin infusion regimes for the induction of labour in women of high parity
Abstract
Objective: To investigate whether in women of high parity induction of labour using a regimen of intravenous oxytocin, increasing incrementally at 45 min intervals, is safer than one increasing at 15 min intervals.
Setting: University of Benin Teaching Hospital, Department of Obstetrics and Gynaecology, Benin City, Nigeria.
Design: Randomised controlled trial.
Subjects: Ninety women of parity 5 or more requiring induction of labour by infusion of oxytocin were randomly allocated to incremental increases at either 45 min intervals (experimental group) or 15 min intervals (control group).
Main outcome measures: Mode of delivery; complications of labour and delivery (uterine rupture, precipitate labour, hyperstimulation, postpartum haemorrhage, perineal tears, puerperal pyrexia); number of days spent in hospital.
Results: The 45 min incremental regimen resulted in longer induction-delivery intervals (estimate of difference in population medians 2 h, 95% confidence interval (CI) 1-4 h); less precipitate labour (odds ratio (OR) 0.09, 95% CI 0.03-0.30); less uterine hyperstimulation (OR 0.23, 95% CI 0.09-0.59); and a reduced length of hospital stay (estimate of difference in population medians 3 days, 95% CI 2-5 days). With the 45 min interval regimen there was a reduction in the occurrence of uterine rupture, postpartum haemorrhage, perineal tears and puerperal pyrexia, but these differences did not reach statistical significance.
Conclusion: For the induction of labour in women of high parity the infusion rate of oxytocin should be increased every 45 min rather than every 15 min until contractions occur three times in 10 min and this infusion rate of oxytocin is maintained until delivery.
Comment in
-
A randomized trial of 45 minute and 15 minute incremental oxytocin infusion regimes for the induction of labour in women of high parity.Br J Obstet Gynaecol. 1994 Jan;101(1):86. doi: 10.1111/j.1471-0528.1994.tb13025.x. Br J Obstet Gynaecol. 1994. PMID: 8155129 Clinical Trial. No abstract available.
Similar articles
-
A randomized trial of 30-min and 15-min oxytocin infusion regimen for induction of labor at term in women of low parity.Int J Gynaecol Obstet. 1993 Mar;40(3):219-25. doi: 10.1016/0020-7292(93)90834-j. Int J Gynaecol Obstet. 1993. PMID: 8096473 Clinical Trial.
-
Incremental increases in oxytocin infusion regimens for induction of labor at term in primigravidas: a randomized controlled trial.Obstet Gynecol. 1994 Feb;83(2):229-33. Obstet Gynecol. 1994. PMID: 8290185 Clinical Trial.
-
Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial.BJOG. 2016 Jan;123(1):129-35. doi: 10.1111/1471-0528.13589. Epub 2015 Aug 26. BJOG. 2016. PMID: 26309128 Clinical Trial.
-
Induction of labour: a randomised clinical trial of amniotomy versus amniotomy with oxytocin infusion.Br J Obstet Gynaecol. 1996 Apr;103(4):306-12. doi: 10.1111/j.1471-0528.1996.tb09733.x. Br J Obstet Gynaecol. 1996. PMID: 8605125 Clinical Trial.
-
Oxytocin induction of labor: a comparison of 20- and 60-min dose increment levels.Int J Gynaecol Obstet. 1995 Jan;48(1):31-6. doi: 10.1016/0020-7292(94)02249-6. Int J Gynaecol Obstet. 1995. PMID: 7698380 Clinical Trial.
Cited by
-
A risk-benefit assessment of oxytocics in obstetric practice.Drug Saf. 1999 Apr;20(4):323-45. doi: 10.2165/00002018-199920040-00003. Drug Saf. 1999. PMID: 10230581 Review.
-
Amniotomy plus intravenous oxytocin for induction of labour.Cochrane Database Syst Rev. 2001;2001(3):CD003250. doi: 10.1002/14651858.CD003250. Cochrane Database Syst Rev. 2001. PMID: 11687061 Free PMC article.
-
High-dose versus low-dose oxytocin infusion regimens for induction of labour at term.Cochrane Database Syst Rev. 2014 Oct 9;2014(10):CD009701. doi: 10.1002/14651858.CD009701.pub2. Cochrane Database Syst Rev. 2014. PMID: 25300173 Free PMC article.